Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Goins

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Annals of Neurology|October 29, 2002
Herpes vector-mediated expression of proenkephalin reduces bone cancer painJames R Goss, Cara F Harley, Marina Mata, et al.
Molecular Therapy. Methods & Clinical Development|July 14, 2017
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE GenesYoshitaka Miyagawa, Gianluca Verlengia, Bonnie Reinhart, et al.
The Journal of Urology|July 29, 2010
Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured ratsMinoru Miyazato, Kimio Sugaya, Seiichi Saito, et al.
Virology|December 13, 2006
Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infectionMarianna Tsvitov, Arthur R Frampton, Waris A Shah, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2016
An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of painBonnie Reinhart, William F Goins, Asaff Harel, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2022
Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectorsSeiji Kuroda, Yoshitaka Miyagawa, Makoto Sukegawa, et al.
Human Gene Therapy|April 10, 2010
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinHitoshi Yokoyama, Katsumi Sasaki, Michael E Franks, et al.
Plos Pathogens|July 6, 2021
Varicella-zoster virus early infection but not complete replication is required for the induction of chronic hypersensitivity in rat models of postherpetic neuralgiaBenjamin E Warner, Michael B Yee, Mingdi Zhang, et al.
Human Gene Therapy|January 16, 2013
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociceptionHitoshi Yokoyama, Tomohiko Oguchi, William F Goins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicityYoshitaka Miyagawa, Pietro Marino, Gianluca Verlengia, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Annals of Neurology|October 29, 2002
Herpes vector-mediated expression of proenkephalin reduces bone cancer painJames R Goss, Cara F Harley, Marina Mata, et al.
Molecular Therapy. Methods & Clinical Development|July 14, 2017
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE GenesYoshitaka Miyagawa, Gianluca Verlengia, Bonnie Reinhart, et al.
The Journal of Urology|July 29, 2010
Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured ratsMinoru Miyazato, Kimio Sugaya, Seiichi Saito, et al.
Virology|December 13, 2006
Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infectionMarianna Tsvitov, Arthur R Frampton, Waris A Shah, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2016
An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of painBonnie Reinhart, William F Goins, Asaff Harel, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2022
Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectorsSeiji Kuroda, Yoshitaka Miyagawa, Makoto Sukegawa, et al.
Human Gene Therapy|April 10, 2010
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinHitoshi Yokoyama, Katsumi Sasaki, Michael E Franks, et al.
Plos Pathogens|July 6, 2021
Varicella-zoster virus early infection but not complete replication is required for the induction of chronic hypersensitivity in rat models of postherpetic neuralgiaBenjamin E Warner, Michael B Yee, Mingdi Zhang, et al.
Human Gene Therapy|January 16, 2013
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociceptionHitoshi Yokoyama, Tomohiko Oguchi, William F Goins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicityYoshitaka Miyagawa, Pietro Marino, Gianluca Verlengia, et al.
Pageof 8